These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2487420)

  • 41. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W; Kotera Y; Koike N; Pilon-Thomas S; Mulé JJ
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):524-33. PubMed ID: 15282530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [MA891--an established spontaneous mouse mammary adenocarcinoma cell line and its immunologic characteristics].
    Zhou Y; Luo L; Liu X; Gao P; Su Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):273-7. PubMed ID: 10453566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice.
    Takeuchi N; Hiraoka S; Zhou XY; Nagafuku M; Ono S; Tsujimura T; Nakazawa M; Yura Y; Hamaoka T; Fujiwara H
    Cancer Res; 2004 Oct; 64(20):7588-95. PubMed ID: 15492286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA; Bigi G; Lucas ZJ
    Cancer Res; 1980 Oct; 40(10):3477-83. PubMed ID: 6449281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in the host lymphocyte subsets during chemical carcinogenesis.
    Brodt P; Lala PK
    Cancer Res; 1983 Sep; 43(9):4315-22. PubMed ID: 6871866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating differentiated T cell localization, activation and chemokine production in established breast cancer.
    Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abulsamad K; Adams SL
    Clin Immunol; 2008 Aug; 128(2):205-18. PubMed ID: 18511346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immune response to inactivated syngeneic mammary adenocarcinoma cells. I. Role and regulation of antibody synthesis in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):125-30. PubMed ID: 6928037
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased immunogenicity of a spontaneous variant clone of the 13762A rat mammary adenocarcinoma.
    Kreider JW; Bartlett GL
    J Natl Cancer Inst; 1985 Jul; 75(1):141-9. PubMed ID: 3859687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stability of the antigen expression in the spontaneous mammary adenocarcinoma during cultivation and absorbtion with immune serum.
    Hakim AA
    Arch Geschwulstforsch; 1977; 47(2):127-37. PubMed ID: 879981
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of tumor growth and cell-mediated immune responses of mice bearing mammary tumors following surgical procedures.
    Lopez DM; Sigel MM
    J Reticuloendothel Soc; 1975 Nov; 18(5):305-12. PubMed ID: 1206665
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunomodulation by soluble factors from tumor cells cultured in vivo in diffusion chambers.
    Klein S; Jasnis MA; Diament M; Davel L; Aguirre J; de Bonaparte YP
    Tumour Biol; 1994; 15(3):160-5. PubMed ID: 7521057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Isolated soluble fractions from spleen cell culture supernatants induce tumor enhancement.
    Eiján AM; Jasnis MA; Motta AB; Oisgold-Dagá S
    J Surg Oncol; 1989 Jun; 41(2):134-8. PubMed ID: 2724981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of tumor growth by soluble spleen factors: effect of tumor resection.
    Jasnis MA; Elján AM; Oisgold-Dagá S
    J Surg Oncol; 1987 Jun; 35(2):139-45. PubMed ID: 3586684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness.
    Parthenais E; Haskill S
    J Immunol; 1979 Sep; 123(3):1334-8. PubMed ID: 313951
    [No Abstract]   [Full Text] [Related]  

  • 55. [Stimulation of antigenicity of renal adenocarcinoma cells].
    Ludes B; Staedel C; Jacqmin D; Cremel G; Hubert P; Saussine C; Beck JP; Bollack C
    J Urol (Paris); 1990; 96(6):295-8. PubMed ID: 2280081
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of growth and metastases in mice by immunization with cholesterol hemisuccinate-enriched tumor cells.
    Skornick Y; Gorelik E; Klausner J; Shinitzky M; Sindelar WF
    Cancer Lett; 1984 Dec; 25(2):153-61. PubMed ID: 6509434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nature of the spleen cell populations capable of releasing tumor enhancing factor.
    Eiján AM; Jasnis MA; Kohan SS; Oisgold-Dagá S
    J Surg Oncol; 1987 Nov; 36(3):161-5. PubMed ID: 3500369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The peripheral myeloid expansion driven by murine cancer progression is reversed by radiation therapy of the tumor.
    Crittenden MR; Savage T; Cottam B; Bahjat KS; Redmond WL; Bambina S; Kasiewicz M; Newell P; Jackson AM; Gough MJ
    PLoS One; 2013; 8(7):e69527. PubMed ID: 23936036
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Oncogenic and antigenic characteristics of ATPC/TC cells].
    Rivosecchi P; Tacconi G
    Ann Sclavo; 1975; 17(2):223-7. PubMed ID: 1227411
    [No Abstract]   [Full Text] [Related]  

  • 60. Presence of a specific immune complex in the cell-free ascites of a spontaneously metastasizing rat mammary adenocarcinoma, TMT-081.
    Ghosh SK; Roholt OA
    Immunol Commun; 1984; 13(1):63-76. PubMed ID: 6735434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.